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Micr~tllia which are consistenlly associatad with Al~hoimer's disease {AD) );chile plaques ~tre part of the monontJcle:tr phailocyte system, ln.vltro 
mmured human monocyte.d©rived m;~crophaltcs rc~t,rc many immunological characteristics ofmicrolilia. We found stronll conslJtutive ©xpr0ss~on 
of' Atxheimcr's//A4.mnyioid precursor protein (APP) in human mononuc|ear pim$ocytes after terminal in.vitro maturation from monoc2ctes to 
macrophalleS, Amyloid has previously been found to b0 ~s~i.nted wilh microgli~t in AD brains, however, it remained unclear whctl~er the material 
was synthesized in or had been phagocytoscd by the ceils, The flndinlts presented here support the ~|ssumption that brain mlcroglia may contribute 
to APP  synthesis in AD brain, 
Macrophage: Micr<)lilia; Arnyloid pr~:ursor protein; AIzheinner'~ disease 
I. INTRODUCTION 
B-Amyloid or A4 protein, now termed .6'A4 protein 
(,~A4), is the major proteinaceous constituent of 
Alzheimer's disease {AD) cortical senile plaques [1] and 
cerebrovascular amyloid [2], It is derived from a large 
precursor protein: /3A4 amyloid precursor protein 
(APP) [3-5]. Three major APP protein forms of 695 
[3], 751 [41, and 770 amino acids [5], respectively, are 
derived from an alternatively spliced hn mRNA. APP is 
synthesized in the brain as well as m several other 
organs and tissues of healthy individuals (for reviews, 
see [6,7]), Until now, only cortical and hippocampal 
neurons, astrocytes, and endothelial cells have been 
reported to be cortical sites of APP synthesis [5, 8-151. 
Although numerous reactiv~ microglia re consistent- 
ly found in and around AD senile plaques [16-19] and 
although amyloid was found to beass0ciated with them 
[17, 18,20] nothing is known so far as to whether this 
cell population of the brain may synthesize APP and 
thus may contribute to ,6A4 deposits, The question re- 
mained open whether the material was synthesized by 
the ceils themselves or whether it had been phago- 
cytosed. Our intention was to obtain evidence whether 
or not human microglia might be able to express APP 
and how it may be regulated, We applied a previously 
described special cultivation system to obtain terminally 
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matured human macrophages from purified peripheral 
blood monocytes which feature many of the character- 
istics of human microglia [21, 22]. The in.vitro matured 
monocyte-derived macrophages share morphological 
and immunological features with microglia: compared 
to monocytes; they show a typical macrophage-like 
ruffled cell membrane under the electron microscope 
[21], and express urface antigens such as MHC class II 
molecules, receptors for Fc, C3, transferrin, and the 
CD4 receptor [23,24], In this report we show that 
monocyte-derived, in-vitro matured human macro. 
phages constitutively express APP mRNA and syn- 
thesize APP protein, 
2, MATERIALS AND METHODS 
2.1, I-Iron<tan mot)ocyte-t~laCrophage cu/iure~' 
Monocyte and monoeyte.derived macroPllage cultures were per- 
formed as pre,Aously described in detail [21,22]: monocytes were 
prepared from blood of healthy donors by centrifugation ver Ficoll- 
Hypaque according to [25]. The mononuelear cell fraction was allow. 
ed to adhere to plastic dishes in supplemented RPMI 1640 medium 
(Seromed, Berlin, FRG) containing 10% human AB serum, Non- 
adherent cells (lymphocytes) were then removed resulting in highly 
monocyte.enriched cultures which were either used immediately for 
experiments or wer¢ further cultivated in order to obtain monoeyte. 
derived macrophages, In the latter case, monocytes were incubated 
overmght and then removed from the dishes at 4°C by vigorous pipet- 
ring and placed, i_n_to rectangular teflon bags (Biofolie 25; Heraeus, 
Hanau. FRG) in supplemented RPMI 1640 medium eontainJn8 10°70 
human AB serum, After g days, the monoeyt¢-derived maerophages 
exhibited features of typical tissue macrophages [23,24]. Cells were 
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removed from the balls, sedimented on platti~ di~h¢~, and: ¢oul~,l be 
tpted for further experim~nt~, 
2, ~, ituman ncnrm~at ¢¢1/eulmrex 
The SH,$YSY neuroblas~oma ¢1~n¢ llfl wa~ a L ¢ i r~ rr ¢.~ Dr J, 
Btedler, Memorial Sloan.,Ketterinll Canter f,,?~nter tNt:w York, N.~,I, 
The cells were ~rown In RPMI 16,40 metlls(m ¢omain|ntl I% FC$ 
(Gibed, Karlsruh¢, Germany). Murl.¢ llerve Ilrowth foe=or tttN¢~F ts) 
(a 8onerous l i f t  from U. Often, I~las,d, Swit;~¢rlandL r¢liaoi¢ achl 
(Stoma, Detsenhofen, Germany), and dtbutyryl (AMP (db cAMP) 
(Sljma) were added |O the medium for ~ days a( a final concentration 
of 20 nl!/ml, 10 pM, and 0,$ raM, resp¢¢tlvd~, Addition or the~e 
components has been prevtoudy reported to result in a differenli,'tletl 
phenolyp¢ of neuronal t:ell~ [2"/), 
,2.3, Radlolabelinll m~d hnnlunoor¢¢lpltotion 
Radiohtbellng of the cell cultures and Immuoopre¢ipitntion wa~ 
done as described earlier in detail [291: cells were plated into 40 mm 
plastic dishes (10 a calls/dish} in supplemented RPMI 1640 medium 
eontainintl I% FCS (neuronal cells) or 1 ~tb human AB serum (rttacro= 
phages), Metabolic labeling was done by replacing media by 
methionine- and serum-free RPMI 1640 medium and by addhlon of 
[)~S]methionine (100 pet/dish), Cells were allowed to incorporate the 
radioactive amino acid into newly synthesized proteins for 4 h e.~¢ept 
in the pulse-chase experiments, where cells were labeled with 200 
pet/dish for only 20 rain followed by addition of an excess of unlabeled 
methionine (2 mM final concentration) in orcler to chase the radio- 
labeled m©tl~ionine, For immunopreeipitation, media were separated 
from (hecells. Cells were homogenized in I ml 25 mM Tris.HCI, pH 
7.5; 20 mM Noel; I% sodium d¢oxycholat¢; lO/o Triton X-100, Non- 
soluble material was removed by centrifugation at 12000 rpm for 5 
minutes. Cell homogenates and media were diluted with 2 ,~olumes of
immunoprecipitation buffer (20 mM Tris.HCI, pH 7.6; O.t4 M Noel; 
5 mM EDTA; Io;o Triton X.100). Total de.horn synthesized proteins 
were determined by TeA-precipitation f 20 ul aliqnots of cell I~omo- 
genates and media according to [30]. Specific proteins were extracted 
from equivalent amounts of total TCA-precipitable radioactivity 
(usually 0,5 x 10 ~' epm from media, 2x 10 6 cpm from cell homo- 
genates). In the paise-chase experiments, specific proteins were ex- 
tracted from total medium and from one half of the cell bomogenate. 
Prior to extraction with specific antibodies, unspecifically binding 
material was absorbed bya sham extraction with non-immune control 
serum. After addition of an excess of monospecific polyclonal anti- 
APP695 antibody [38] (usually 10 all the imnauue complexes were 
bound to Protein A Sepharose (Pharmacia, Freiburg, FRG), sedi- 
mented, and washed (2 times in immunopreci ~itation buffer, 2 times 
m 50 mM sodium phosphate buffer, pH 7,5). The immune complexes 
were dissociated at 95°C for 5 rain in 35 lal of dissociation buffer (0.1 
M Tris-HCl, pH 6.8; 5% 2.mercaptoethanol; 5% sodium dodecyl- 
sulfate; 10070 glycerol), subjected to sodium dodecylsulfate polyacryl- 
amide gel electrophoresis (SDS-PAGE) according to [31], and fluor- 
ography according to [321. The specific radioactive bands were cut out 
from the gels, solubilized with protosol/water (9 : 1) and counted in a 
liquid scintillation counter. 
2.4, DNA constructs 
Standard cloning techniques were applied [33]. A partial ,qA4- 
amyloid precursor protein/APP77o eDNA of 2,7 kb was isolated 
from a human fetal brain lambda gtl0 eDNA library using radio- 
actively endlabeled oligonucleotide probes specific for the APP770 
eDNA as welt as a BamHI/Xhoi  restriction fragment (-47 to + 1135. 
[3]), which was labeled by random priming [34, 35], A 1.7 kb EcoRl 
fragment of this eDNA, where the 5'-EcoRI restriction site derived 
from the adaptor (Eco R!-XhoI-SalI) used during construction fthe 
eDNA library, and the 3".Ecogl site at position +2020 from the 
APP77o eDNA, was subcloned into the EcoRI restriction site of the 
pUC 19 polylinker, resulting  the recombinant plasmid p2.21. Diges- 
tion of plasmid p2.21 with Xhol resulted in a fragment with 815bp 
of APP77o eDNA. This fragment was cloned into the Sail restriction 
~it¢ of lh¢ M i )mpl l  i~olyttnker, rouhinll tn re¢omblnam pha~e 
MS. 1 I, 
ldJ, RN:I ¢,~lr#¢ti~n ,md ~J m¢¢t¢¢~¢ prmccfton ets~o.v 
Total NNA was eslra¢led from eell~ aegordtnlt to (;t6], The SI 
nu,dease protection aata~ war, performed at doeribed I:~'q. A nnt. 
formlY' labeled sinltle.slranded DNA prone wa~ynthe~i=¢d by ann~l- 
inll I pmeJ of M I .~ pl~l~¢ st~ctfi¢ olillonuclc~stde primer to 2:50 nB of 
sint=le.stranded template DNA of Mil. 11, Thi~ palmer was extended 
with i unh Of glenow polymeras© (Bo¢l~rtnl=er, Mannheim, Germany} 
In the presence or 2:~ mM d^TP, dGTP, dT3'P, I mM dCTP, and 40 
gel or [¢tJ:PldCTP O0t] Ci:mmol] f,~r 15 rain at 3"PC. Extended 
produc(~ were dtllested with S~¢1 for 4~; rain, The labeled single. 
stranded DNA.probes were purified oR u .~% dena;urinjl 
polyaerylamid¢ ttel, Probes were visualized byaatoradioltral~hY, Gel 
~lico ¢orrespondini! Iv (lie bards on the gutoradioilraph were cut oat 
a;td ele=troeluted (Elutrtzp, Sdtletcher and Seh¢lll), Excess probe 
MS. I I ('JO000 ~pm) was hybridized overnittht (o 1~ Pl~ of total RNA 
at ~$'C' ('IS*,',= formamlde, 0;4 M N'tCI, 20 mM Tris.HCI, pH ?,4. and 
I mM E DTA}, S I nu¢lea~;e digest Ion (I 200 units/sample; Boeltrinl/,er, 
Mannheim, Germany} was performed for 2 h at 37"C [0,3 M NnCI, 
3 mM ZnSO4, 60 mM NaA¢. pH 4,$, 0.5 tag denatured calf thymus 
DNA). The resnhinl/, products were once pi~enol, and once 
phenol/eliCit.extracted, ethanobpre¢ipitated and resolved on a S~o 
denaturinil sequencin~ gel. Autoradiogrllphy was done with Kodak X. 
OMAT AR films, 
2,6. InttmtiioO.IOchentleal 816ffninR 
Monocyte.derived mac~'opltages were plated in 1640 medium on 
(hermanox plastic coverslips (Nuns, Ill, USA} and allowed to adhere, 
Cells werethen washed wit h phosphate.buffered saline (PBS) and fixed 
with 4~o formalin PBS, After ineub:ttion with a I : l0 dilution of(he 
monospeciflc primary antibodies: monoclonat anti.BA4.amyloid 
precursor protein (Boehringer, Mannheim. Germany} or polyclonal 
anti alpha 2.macroglobulin [281, cells were treated with the Vectastain 
AgC.peroxidase detection system (Vector Lab.. Burlingame, CA), 
Cells were mounted inglyeeringelat ine (Merck, Darmstadt, Germany) 
and viewed with a Zeiss !11 RS microscope, 
3, RESULTS 
In-vitro matured macrophages were obta ined by  sub- 
jest ing puri f ied human peripheral b lood monocytes to 
cult ivat ion in hydrophobic  teflon foils for 8 days. Dur-  
ing this t ime, the cells increase in size (Fig. 1A) and 
develop features of  tissue macrophages [23,241. In 
freshly isolated blood monocytes synthesis of BA4- 
amylo id precursor prote in (APP)  was near ly  unde-  
testable (Fig. IB, lane 1). However,  after terminal  
maturat ion  macrophages express high levels of APP  
both on the prote in (F ig .  1B, lane 2) as well as at the 
mRNA level (Fig. 2). I f  RNA extracted f rom 
macrophages was analyzed by S1 nuclease protect ion 
analysis, APP  mRNA coding for the 751 and for the 
770 amino  acid forms of  the APP  prote in  were found to 
be predominant ,  while only a faint  signal was detected 
corresponding to the mRNA coding for the 695 amino  
acid form of  the protein (Fig. 2). 
The biosynthesis and secretion of  APP  was analyzed 
by a pulse-chase study. A compar ison  of synthesis and 
secretion in macrophages (Fig, 3, lanes 1-4) and  human 
neurona l  (SH-SY5Y neurob lastoma)  cells (Fig. 3, lanes 
5-8) revealed, that macrophages synthesize intracel lular 
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Fig. 1. (A)Morpholol~ical charactet,zation of in.vitro maturated lauman macrophages compared t  freslfly isolated Iluman blood monoeytes 
Pappenheim-stained fresldy prepared I~umnnblood monocytes (left) and macrophages ,after in-vitro maturation (rigltt) were viewed by oil itnmer- 
sion mtcrosc~3y at the same magnification (x24CI0) for both pictures, (B) Secretion oft?A4-amyloid precursor protein (APP) by rreshly isolated 
human blood monoeytes and by in-vitro naaturated macrophage.~. Adherence-purified human blood monocytes (lane 1) and In.vitro maturated 
macrophages (ladle 2) were metabolically radiolabeled, APP was immunol~reeipitated from .~tandardized amounts of secreted TCA.preelpilable 
radioactivity (i.e. from standardized amounts of de.novo synthesized proteins) as described inSection 2, subjected to SDS-PAGE and autoradio- 
~raphy. 
APP  forms with an apparent molecular weight between 
1 10 kDa and 130 kDa (Fig. 3, lane 1) corresponding to 
the N-glycosylated forms of  APPTsz and APP~7o (about 
110 kDa) and to the N- and O-glycosylated thyrosine 
sulfated mature membrane protein APP751 and APP77o 
(about 130 kDa) [38]. The same pattern was found in 
neuronal cells (Fig, 3, lane 5), however, these cells con- 
tained an additional APP  form of  approximately 98 
kDa (lane 5, arrowhead). Most  likely, this neuron- 
specific form represents N-glycosylated APP69 ~ ([38] 
see below). Secretory APP  forms in the macrophage- 
condit ioned medium had a molecular weight between 
110 kDa and 125 kDa (Fig. 3, lane 4), Again, a neuron- 
specific additional APP695 form gives rise to nr~ addi- 
t ional band with a molecular weight of  approximately 
92 kDa (lane 8, arrowhead). 
Molecular weight heterogeneity of  APP  has previous- 
ly been shown to be due to the facts: first, that 3 dif- 
ferentially spliced major APP  mRNA forms (coding for 
APP proteins with 695,751, and 770 amino acids) are 
derived from hn mRNA t3-5]; second, that APP  is sub- 
"jected to  posttranslational modifications including N- 
and O-glycosylation, sulfation, and proteotysis [38-40]. 
The secretory APP  forms found in the conditioned 
medium are produced by a proteolytic leavage C- 
terminal to residue 16 of the/~A4 part of the mature 
APP  transmembrane forms [39,40]. 
The presence of APP in macrophages was finally 
demonstrated by immunocytoehemicaI staining. Figure 
4A shows strong intracellular (mainly perinuclear) 
f lAPP immunoreactivity in macrophages. In addition, 
cells from the same preparation stain also for alpha-2- 
macroglobulin (Fig. 4B), a previously described marker 
of terminally matured macrophages [28]. 
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Fig. 2, Detection of APP mRNA in freshly isolated human blood 
monocytes and in-vitro maturated macrophages by S[ nuclease pro- 
tection assay, 15 I-Lg of total RNA From freshly isolated ltamaa blood 
monocytes (lane l) and from in.vitro maturated macrophages (lane 2) 
were hybridized to an e.~cess of APP probe MS. l I and digested with 
St nuclease. The resulting protected fragments w re subjected to a 
5olo denaturing polyacrylamide get lectroplioresis. The protected 
fragments of 81S bases for the flAPP770 mRNA, of 714 bases for the 
/IAPP~I mRNA and of 546 bases for the //APP~vs mRNA are in- 
dicated. 
4. DISCUSSION 
As the resident macrophages of  the brain, microglia 
are linked to the mononuclear phagocyte system (for re- 
cent reviews see [41-43]). Here we describe that cells of  
the mononuclear phagocyte system, linking bone mar- 
row precursors, blood monocytes,  and the different 
tissue macr.~phages, strongly express APP upon ter- 
minal maturation from monocytes to macrophages. 
Treatment of  the macrophages with endoto×in (a 
classical s t imu lans)or  glucocorticoids did not affect 
APP synthesis (not shown). Like in other non-neuronal 
cells [44-46], APPTs I and APP770 are the major  APP  
forms in macrophages. Expression of APP695 is nearly 
exclusively restricted to neuronal cells where it is ex- 
pressed in a [751+770]:[695] ratio of about 1:1 
[44-46]. Several reports describe an increased ratio of  
[751+770]:[695] APP  mRNA in AD brain [4%49]. 
This finding may be explained by an age-dependent 
alteration [50] and/or  by gliosis which is commonly 
observed in AD [48]. It remains to be elucidated whether 
the changed ratio in APP  expression is an early or late 
event of  Alzheimer's disease pathophysiol0gy. 
In AD brain, senile plaques are consistently found to 
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Fig. 3 Comparison of the APP forms synthesit.¢d ~nd secreted by in- 
vitro maturated human macrophages and by hUlTian nellrona~ (neuro- 
blastoma) cells. In-vitro maturate,J human macroplmges (lanes !-4} 
and human SH-SYSY neuroblastom;t cells were pulse-labeled with 
200 ~tCi of [-~:~5Jmethionine [or 20 mia, Th~n the cultures were 
harvested either immediately (Imtes 1,3, 5,7) or cultivated for 4 more 
hours iz~ the presence of an excess of unlabeled methionine (2 mM 
final concentration) in order to clmse tile incorporated radioactive 
methionine (lanes 2,4,6,8). Cultures were harvested by separating 
culture media front cells. APP ,,,,.as imn'~unoprecipitated from half 
volume of cell homogenates (lanes 1,2,5,6) and from total media 
(lanes 3,4,7,8), subjected to SDS-PAGE and autoradiograpbed. Un- 
specifically binding material was preabsorbed from cell homogenates 
(Pc) and media (P,,~) using non-imrnune control serum. Arrowheads 
point to an APP form produced in neuronal cells only. 
contain and to be surrounded by reactive microglia 
[18-20]. Resident microglia are derived from immi- 
grating monocytes which then undergo terminal matura- 
tion into resident microglia [18-20]. This immigration 
occurs mainly in the perinatal period, but a low degree 
of  immigration has been assumed to occur throughout 
life [18-20]. In jury  or infection in the central nervous 
system give rise to the appearance of both reactive micro- 
gila (i.e. activated resident microglia) and  activated 
macrophages (i.e. mononuclear phagocytes recruited 
f rom the circulation) [41-43]. The local environment 
may influence the behaviour of  resident macrophages in 
the different tissues. Therefore, data obtained with in- 
vitro matured macrophages must be interpreted with 
caution. It is impossible to determine to which of the 
microglial cell types (resident microglia, activated 
microglia, or activated macrophages) our in-vitro 
matured macrophages are best correlated. However, 
¥olumt~ 2~2, ngmber ~ FI~RS L,~,TTI~R~ M=ty 1991 
Fi=, 4. lmmunoc:ytochemical =¢aininl) for AtoP of in.vilro-malura~ed ma<rophalle~ with a monoclon~tl a)tlibody directed tt=atnst #A4.~tmylold 
precursor prowin (At mid a poly¢lonal ~ntib~)dy direeled tlHain~t aipi~a 2.nta~:roNlohutift (B), Control ~latn~t wit It r~tbblt non.immune ~erum were 
co.mplclely wilhou! ~¢aln (nOt ~|tOWll), M~tl~fllHea|lon ~¢37~, 
since APP expression was not altered upon stimulation 
of our ceils with the classical activator endotoxin, the 
state of activation seems to be of minor significance for 
APP expression. Instead, APP expression seems to 
critically depend upon the terminal step of mononuclear 
phagocyte maturation, We assume that APP expression 
of in-vitro matured macrophages tr~ay serve as evidence 
for synthesis in microglial cells. Very recently, this 
assumption was supported by immunocytochemical 
detection of APP in primary cultures of human micro. 
gila (P. Gebicke-Haerter, J. Bauer, B. Volk, in prepara- 
tion). 
The physiological functions of APP are still unclear. 
The secretory (N-terminal) part of APP751 (which) like 
APP77o, bears a Kunitz-type protease inhibitor domain) 
has been found to be identical to protease nexin II 
[51, 52]. Functions of this molecule include inhibition of 
coagulation factor XI a, plasmin, trypsin, chymo. 
trypsin, and nerve growth factor gamma {which is in- 
volved in NGF processing) [5,51-55]. In addition, 
binding to epidermal growth factor binding protein and 
to transforming growth factor beta has been observed 
[51,52, 54, 56]. Since n eurite outgrowth depends on a 
precarious balance between proteases and their in- 
hibitors [57], it appears conceivable that the protease 
inhibitors APP751 and APP77o naay interfere with 
neuronal plasticity. With respect to the ,6A4 peptide, its 
effects on undifferentiated neurons seem to be 
beneficial and to support neuronal differentation 
[58, 59]. In contrast,/~A4 was found to exert neurotoxic 
effects on differentiated neurons [59-61]. 
The mechanisms by which APP contributes to the 
pathology of Alzheimer's disease are not yet fully 
understood. A detailed analysis of APP biosynthesis in
cultured cells revealed that APP, after its insertion into 
the cell membrane as a transmembrane protein [3, 38, 62], 
is cleaved inside the/~A4-sequence of the mature APP 
protein by a still unknowr= secre~ase r sulting in"fl~e 
secretory release of the large N.terminal portion of 
APP [39,40]. Therefore, it can be concluded that the 
formation of the J3A4 peptide is prevented under nor.. 
real physiological conditions. Vice versa, it appears 
conceivable that a protease inhibitor may inhibit tile 
APP secretase in Alzheimer's disease (AD) and may 
thus preserve the /3A4 peptide from being cleaved. 
Pathologic APP breakdown could then give rise to flA4 
~vhich due to its tendency to aggregate may contribute 
to plaque formation. In fact, we recently found that 
human neuronal cells synthesize and secrete the most 
potent of the known endogenous protease inhibitors, 
alpha2..macroglobulin (a2M), upon stimulation with 
the inflammatory cytokine interleukin.6 (IL-6) [63]. 
a2M was found to inhibit APP secretion [63] and both 
a2M and IL-6 could be detected in AD senile plaques 
(g. Volk and J. Bauer, submitted). 
Once normal APP processing is disturbed, APP from 
any source inside the brain might contribute to ,~A4 and 
subsequent plaque formation. Our data show that tissue 
rnacrophages contribute to APP synthesis and thus pro- 
vide evidence that APP may be synthesized also by 
brain microglia. Ho~vever, further studies have to be 
carried out to elucidate how exactly microglial cells may 
contribute to the pathophysiology of Alzheimer's 
disease. 
Ackttowledgements: This work was supported by grants from the 
Deutsct~e Forschungsgemeinschaft {DFG) (J.B, by SFB 154; K.B. by 
SFB 317) and from tide Fritz Thysser= Sliftung (J,B.), G,K, is a fellow 
of the Boehringer lngelheina Fond. 
REFERENCES 
[1] Masters, C.L,, Simms, G,, Weinmann, N.A., Malthaup, G., 
McDonald, B,L, and Beyreuther, K. (1985) Proc. Natl, Acad 
Sci. USA 82, 4245-4249. 
339 
Volume Iit2, number 2 FEBS Lt~TTER$ M=y 1991 
Ill <')lerm¢t, G.G. and Woflll, C.W, 4181t41 Itit~¢hem, Itlophy~, Retd. 
Common, 120, 88~-890, 
13] Kant=, L, Lcmmir¢, H J3,, Unl¢rbe¢k, A,, S¢tlb~mm J.M,, 
Mmsler, C,L,, ¢.-~rxe~tcht~:k, K,H,, ~luhh~up, G., B~yr~ulher, K, 
~md MiIINr-Htlh B, (1911'~) Nature .125, "~LI-'~36, 
14] Panl¢, P.+ Gon~tdt~.DeWhitt. P,. $¢hilltn~h J.. Millet, J., I'l~u, 
D,. Gr¢~nb¢rM, It,, Dart.t, K;, Wallace, W,. Lleberhurt=, I,, 
Fuller, F, and C'ord¢ll, II, (191181 Nature 1~1, $25-$.~7, 
[:ll Kitailu¢hl, N,, 'l'ttkallttdd, Y., Toku+hima, Y,, $hijiri, ~;, and 
lira H, (19118) Nature 311, ~30-$32, 
16] Milller.Hilh B, and Beyreullwr, K, t1989} Anna, R~v, l~io~h<m, 
~8, 287-30"L 
['/1 Selkoe, D,J, (19901 Science 248. IO~ta-1060. 
18) Bahmar~yar, S,, Hi,trim;, G,A,, Goldl~aber, O., ke~i~, D.A,, 
Morri$on, J,H., Wilson, M,C., Sltankar, S,K. and Gajdu~¢k, 
D,C. (198"/) S~:Nnee 231.77+~0, 
[9] Goedett, M, (1987) EMBO J, 6. 3627-36~2, 
[101 Shlver.~, B,D., Hilbleh, K,, Mttkhaup, G,, Salbanm, M., 
Beyreuther, K and Seeburl/,, P,H, (1988) EMBO J, 7,116~-1370, 
[lll Fliilsin+, G.A., Lewis, D,A,, Bahmal~yar, S,, Gold~,aber, D,, 
Gaidusek, D.C,, Yoanli, W.G., Nlorrtson, J,H, and Wihon, 
M,C, (19881 Proc, Nail. Acad. Sol, USA 8~, 129"/-1301. 
1121 Tare.as(raft', B,i Majocha, R,E, and Marotta, C.A. (19891 
Proc. Nail, Acad, Sci, USA 86, 745-749, 
[131 Grundk¢-hlbal, I,, lqbal, g,, George, L., Time, Y.C,, Rim, 
K.S, and Wisniewski. H,M, (1989] Proc, Nml, Acad Sci, USA 
86, 28~3-2857. 
[14] Benowitz, L,I,, Rodriguez, W., Paskevich, P,, Mafson, E,J,, 
Schenk, D, and Neve. R,L. (1989) Exp, Neural, 106, 237-250. 
[151 Chou, W.G,, Zain. S,B., Rehman, S., Tare.as(roll, B,, 
Majodta, R,E,, Benes, F,M, attd Marotla, C,A, (1990) J, 
Psychiatr. Res, (1990) 24, 37-50, 
[16] Wisniewskl, H,M, andTerry, R,D, ¢.19731 in: Progress in Neuro. 
pathology (Zimmermann, H M,, cd,) Grune and Stratton, New 
York, pp, 1-26. 
[17] Kozlowski P,, Wisniewski; H,M,, Moretz, R.C. and Los,~insky, 
A,S, (19811 Ann, Neural, 10, 517-523. 
[18] [tagaki, S., McGeer, P,L,, Akiyama, H,, Zhu, S. and Selkoc, D, 
(1989) J, Neuroimmunol, 24, 173-182 
[19] Styren, S,D,, Civin, W,H, and Rogers, J, (19901 Exp. Neural, 
I10, 91-104, 
[20] Perlmutter, L,S,, Barton, E. and Chang Chui, H, (19901 
Neurosci, Lett, 119, 32-16, 
[21] Bauer; J ,, Ganter, U,, Geiger, T,, Jacobshagen, U,, Hirano, T,, 
Matsuda, T,, Kishimoto, T,, Andus, T., Acs, G,, Gerok, W, and 
Cilibcrto, G. (1988) Blood 72, 1134-1140, 
[22] Bauer, J., Bauer, T,M,, Kalb, T. Taga, T,, Lengyel, G,, 
Hirat~o, T,, Kishimoto, T,, Acs, G,, Mayer, L, and Gerok, W. 
(1989) J, Exp. Med, 170, 1537-1549, 
[23] Andreesen, R,, Gadd, S,, Brugger, W,, Lbhr, G,W, and Atkins. 
R.C, (1988) lmmunobiology 177, 186-198, 
[24] Andreesen, R,, Brugser, W., Scheibenbogen, C., Kreutz, M,, 
Leser, H.G,, Rehrn, A, and Lbhr, G,W. (1990) J, Leukoc. Biol. 
47,490-497. 
[25] Boyum, A, (19761 Stand, J Immunol. 5, 9-15, 
[26] Biedler, J,L., Roffler-Tarlow, S., Schachner, M. and Freedman. 
L.S, (19871 Cancer Res, 38, 3751-3757. 
[27] Bottenstein, J ,E, (19811 in: Functionally differentiated cell lines, 
Alan R. Liss, New York, pp, 155-184, 
[281 Ganter, U,, Bauer, J., Schulz-Huotari, C., Gebicke-Haertcr, 
P.J., Beeser, H. and Gerok, W, 41987) Eur, .I. Biochem, 169, 
13-20. 
[291 Bauer, J., Kurdowska, A., Tran.Thie, T.A,, Budek, W,, Koj, 
A,, Decker, K, and Heinrich, P.C. (19851 Eur, J, Biochem. 146, 
347-352. 
[30] Marts, R,J, and Novelli, G,D (19611 Arch, Biochem. Biophys. 
94, 13.48. 
[31] Kin~, J. and Ltimmli. U, (19711 J, Mol. Biol 62, 465-477, 
[32] Banner, J, and Laskey, R.A, (19741 Eur, J, Biochem, 46, 83-88. 
I):tl Au~bubch F,M,, Itr¢m, R,. K tat+ion, R,IL, Mm~r©. D,D,, 
S¢ldmaa, J LL, ~millt, J.A, and.~hruld, K.. {?u~¢~al I:~¢o1@~1~ in 
Mol¢~ul~t B|ulc~IIX, J~hll WIley & ~on~, N~w Ymfk, l~IQ, 
I~1 bl~inkoth. J. mad Wahl, ¢d. [19114) Aural, Dlodl,cm, i)l~, 267=21~4, 
l;~ml Chtm'i,+~yn,t, kh P. aad S.+,:~l~|, N. (191171 Anml lJbjchcm. I~+], 
I ~6-16o. 
1~t71 Rupp+rl, C,. t3oldowh,~. 13. and Will¢, W, (11t~61 EMllO J, ~,. 
1897219OI, 
[~1 Weid¢mmnn. A,, K0ni~, tr,, ltunke, D,. Fi~¢hcr, P., ~;~lbaum, 
J,M., Ma~lcr~, C.L, and B~yrculhcr, K. (l~lt~ Call ~',t, i 1~+126. 
l:~gl Sho¢lla, $,S.. Ko~ E;Id,, lteyr+tlth+r, K,, Umer~¢ek, A, and 
Pri,:e, D.L. 41990] S¢i~n~:¢ ~48, 492=49~. 
[401 E+eh, F.S,, K+im, P,S,, B~atlht, ff.¢,, Bla¢he¢, R,W,. Cuhv¢lh 
A.R,, Oltcrddorf, T,, M~:Chmt, D. and Ward. P,J. (1~901 
Sclen¢~ 24~, 1122-1124. 
PerrY, V.H. aitd (Jordorh S. (1981~) Tr+ndr, Ns:urol, S¢i, 6, 
2"/3-277, 
Streit, WJ . ,  Gra~:bn¢r. M.B. m~d Krcu|,tbcrt~, G,W. (I 9H81 GIIa 
I. 101 - ~lO'/. 
Jordan, F,L and Thom~,,, W.E, (191~8) Brain R¢~, R~v I1, 
165-178, 
Tanzi, R,E,, ,M¢Clatch~y, A,l., t.amperti, E.D,, Villa. 
Komaroff, L,, Gu++dla, J,F, and Neve, R,t., 41988) Nature ~31, 
528-£~0, 
Koo, E,H., Si~oditt, S.S.. Archer, D,R,, Martin. L.,J,, We)de. 
mann, A,, [leyreather, K., Fischer, P,, Master, C,L,. anti Price, 
D.L, 41990) Pro¢, Nqtl, A~ad. S¢i. USA 87, 1~61-156~,, 
[46] Kane,, J. and Mfillcr.Hilh B, (1990) Bioch¢m, BioplWs, Re~, 
Comman.  166, I192-1200, 
[47] Johm+on, S.A., MeNeilh T,, Corddl, B. and Finch. C,E. 41990) 
Science 248, 854-857, 
[481 Golde, T,E,, r:stus, S,, Usiak, M,, Younkin, L.H. and Younkin, 
S.G, (19901 Neuron 4. 153-167, 
[491 Koo, E,H,. Shodia, S,S,, Cork, L,C, Unterbeck, A., Baynay, 
R,M, and Price, D,L, (19901 Neuron 2, 97-104 
[50] K~3niB, G,, Salbaum, J,M,, Wiestler, O., Lanl], W., Schmitt, 
H,P,, Masters, C,L, and Beyreuthcr, K, 41991) Mol Brain Res, 
tin press), 
[51] Ohersdorf, T,, Fritz, L,C,, Schenk, D.B,, Lieberburg, 1., 
Johnson.Wood, K,L,, Beat(it 12,C., Ward, P.J., Blacher, 
R,W,, Dovey, H.F, and Siuha, S. (1989) Nature 341, 144-147, 
[52] Van Nostrand, W,E., Wagner, S,L,, Farrow, J,S. and Cunning- 
ham, D.D. (1990) .I, Biol, Chem, 265. 9591-9594, 
[531 Kido, H,, Fukutomi, A., Schilling, J,, Wang, Y,, Cordelh B. 
and Katanuma, N (19901 Biochern Biopnys. Res, Commun. 
167, 716-721, 
[541 Sinha, S., Dovey, H,F., Seubert, F'., Ward, P.J., Blacher, 
R,W,, Blaber, M,, Bradshaw, R,A,, Ariel, M,, Mobley, W,C, 
and Lieberburg, 1, (1990) J, Biol, Chem. 265, 8983-8985, 
[551 Castro, M., Marks, C,B, Nilsson. B, and Anderson, S, (19901. 
FEBS Lett, 267,207-212 
[561 Bodmer, S,, Podlisny, M,B,, Selkoe, D.J., He)d, I, and Fontana 
A. (19901 Biochem, Biopl~ys, Re . Commun, 171, 890-897, 
[571 Monard, D, (19881 Trends Neural. Sci. 11, 541-544, 
[58] Whitson, J,S,, Selkoe, D,J, and Co(man, C.W, 41989) Science 
243, 1488-1490, 
[59] Yankner, B,A,, Dully, L,K, and Kirschner, D.A, (1990) Science 
250, 279-282. 
[60] Yankner, B,A,, Dawes, L.R,, Fisher, S,, Villa-Kornaroff, L,V., 
aster-Granite, M L, and Neve, R.L. (1989)Science 245,417-420, 
[611 Yankner, B.A,, Caceres, A, and Dully, L,K, (19901 Proc. Natl, 
Acad, Sci USA 87, 9020-9023. 
[62] Dyrks, T., Weidemann, A,, Multhaup, G,, Salbaum, J,M,, 
Lemaire, H,G,, Kang, J,, Mtilter-Hill, B,, Masters, C,L, and 
Beyreuther, K, (19881 EMBO J. 7, 949-957. 
[63] Ganter, U,, Strauss, S,, Jonas, U.; Weidemann, A , Beyreuther, 
K,, Volk, B,, Berger, M, and Bauer, J, (19911 FEBS L¢tt, (in 
press). 
l.lll 
I,t~.1 
[411 
1441 
[451 
340 
